Late phase clinical trials are essential for evaluating the safety and efficacy of drugs before they are approved for use by the general public. These trials require significant resources, time, and expertise, making it challenging for pharmaceutical companies to conduct them in-house. This is where Contract Research Organizations (CROs) come in. In this article, we will discuss the role of CROs in late phase clinical trials in India.